Associate, Asset Acquisition, GondolaBio

Description

About GondolaBio

GondolaBio is a clinical-stage biopharmaceutical company focused on developing next-generation therapeutics for genetic diseases. Originally launched as BridgeBioX, a subsidiary of BridgeBio, GondolaBio secured $300M in private financing from external investors in 2024 and became an independent company within the BridgeBio ecosystem. The company aims to leverage cutting-edge biological research to create breakthrough medicines addressing high unmet needs across multiple therapeutic areas, including neurology, pulmonology, cardiology, nephrology, and endocrinology. Located on the Stanford Life Sciences campus, GondolaBio fosters a unique hybrid environment where top scientists from around the world collaborate with senior leadership and advisors, blending industry expertise with academic innovation.

About BridgeBio

BridgeBio is a commercial stage biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. Our focus on scientific excellence and rapid execution aims to translate today’s discoveries into tomorrow’s medicines. We bridge the gap between remarkable advancements in genetic science in academic institutions and the delivery of meaningful medicines to patients. Founded in 2015, the company built a portfolio of 22+ drug development programs ranging from preclinical to late-stage development in multiple therapeutic areas including precision oncology, cardiology, endocrinology, neurology, pulmonology, renal disease, and genetic dermatology, with three approved drugs. We have U.S. offices in San Francisco, Palo Alto, and Raleigh. We also have international offices in Montreal, Canada, and Switzerland.

Who You Are

GondolaBio’s Asset Acquisition team is seeking an Associate to help us define our new programs. We are looking for ambitious scientists who’d like to contribute at the intersection of science and business. Our team is responsible for finding, evaluating, and determining which therapeutic ideas GondolaBio will pursue, with an emphasis on evaluation of the scientific rationale behind therapeutic strategies. The team works closely with GondolaBio’s Investment Committee, which is composed of veteran drug developers and renowned academic scientists. Across the BridgeBio ecosystem, we have spearheaded partnerships with academic and industry groups to create, fund, and operate >30 new drug development programs. As a key member of the team, this position will help set the culture and business development of the company and will be the face of the organization.

Requirements

Responsibilities

• •Identify promising new preclinical or early clinical stage programs to treat genetically driven diseases through deep engagement with the literature, academic and industry experts, and internal development efforts
• •Deeply evaluate all aspects of a potential therapeutic program—from genetic rationale and pre-clinical evidence all the way to the development plan and clinical trial design
• •Advocate for those that fit our goal of targeting the genetic source of a disease by building a scientific and business case for each potential investment
• •Interface with leading academics, patient advocacy groups, biotechs, and entrepreneurs
• •Lead internal discussions with management and the Investment Committee
• •Establish a focused investment strategy and follow through to identify new investment opportunities
• •Coordinate and work with a talented team of internal subject-matter experts—including clinical, commercial, and disease experts—to dive as deeply as needed for each project

Education and Experience & Skills Requirements

• •You are patient driven - Everything we do impacts the life of a Patient
• •You have a strong aptitude and detailed curiosity for science (you devour journals for breakfast)
• •You hold an advanced technical degree (PhD, MD, or MD+PhD) in the life sciences and/or medicine, from a top-tier academic institution.
• •Postdoctoral or residency training is a strong plus.
• •You have a demonstrated record of scientific achievement as evidenced by lead-author preprints / publications, grants, patents, scholarships, or awards
• •You have previous experience at one of the following:
• •Management Consulting or Venture Capital experience from top tier firm, with significant experience in diligence. Business development role in a biotech or life science startup
• •Postdoctoral fellows and/or medical residents, with demonstrated experience or strong interest in the business of biotechnology
• •You have demonstrated the ability to thrive in an intense environment - whatever your background, you are pressure tested
• •You are a master “improviser” - so much of the drug development world is unpredictable, you must be comfortable with a significant degree of ambiguity
• •You have the confidence to chart your course - you can identify problems, locate the resources, and find data-driven solutions independent of supervision
• •You have an unrivaled sense of urgency - like our unique drug development processes, you will need to optimize for speed

No matter your role, successful team members are:

• •Patient Champions, who put patients first and uphold strict ethical standards
• •Entrepreneurial Operators, who drive toward practical solutions and have an ownership mindset
• •Truth Seekers, who are detailed, rational, and humble problem solvers
• •Individuals Who Inspire Excellence in themselves and those around them
• •High-quality executors, who execute against goals and milestones with quality, precision, and speed

What We Offer

• •Patient Days, where we are fortunate to hear directly from individuals living with the conditions we are seeking to impact throughout the year and learn how we can improve our efforts
• •A culture inspired by our values: put patients first, think independently, be radically transparent, every minute counts, and let the science speak
• •An unyielding commitment to always putting patients first. Learn more about how we do this here
• •A de-centralized model that enables our program teams to focus on advancing science and helping patients. Our affiliate structure is designed to eliminate bureaucracy and put decision-making power in the hands of those closest to the science
• •A place where you own the vision – both for your program and your own career path
• •A collaborative, fast-paced, data-driven environment where we inspire ourselves and each other to always perform at the top of our game
• •Access to learning and development resources to help you get in the best professional shape of your life
• •Robust and market-competitive compensation & benefits package (Base, Performance Bonus, Equity, health, welfare & retirement programs)
• •Flexible PTO
• •Rapid career advancement for strong performers
• •Potential ability to work on multiple BridgeBio Pharma programs across multiple therapeutic areas over time
• •Partnerships with leading institutions
• •Commitment to Diversity, Equity & Inclusion

The base pay range for this position is $130,000 to $170,000 per year. The actual compensation offered will be determined based on a number of job-related factors, including experience, skills, qualifications, and location. A bonus plan and equity will also be offered.

GondolaBio ServiceCo is an equal opportunity employer. All applicants will be considered for employment without attention to race, color, religion, sex, sexual orientation, gender identity, national origin, veteran or disability status. Employees of BridgeBio and all affiliated companies should work through their managers to inquire about and learn more about this role.